Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Biomind Labs Inc N.BMND

Alternate Symbol(s):  BMNDF

Biomind Labs Inc. is a biotech research and development company. It is focused on transforming biomedical sciences knowledge into novel pharmaceutical drugs and nanotech delivery systems for a variety of psychiatric and neurological conditions. Through its acceleration platform, Biomind Labs is developing novel pharmaceutical formulations of key endogenous substances which are occurring in the human body and an organic compound that includes many neurotransmitters for treating a range of therapeutic indications. DMT is a serotonergic psychedelic that exerts its effects through serotonergic receptors in the brain, including 5-HT2A, 5-HT1A, 5-HT2C and 5-HT7 receptors. 5-MeO-DMT is a powerful psychedelic tryptamine. Under the 5-MeO-DMT Program, it is focused on two drug candidates: BMND05: 5-MeO-DMT novel formulation indicated for Chronic Pain and BMND08: 5-MeO-DMT novel formulation indicated for Alzheimer’s disease. Mescaline is a psychedelic alkaloid of the phenethylamine class.


NEO:BMND - Post by User

Bullboard Posts
Post by DTM5on Apr 26, 2010 8:34pm
578 Views
Post# 17033265

Plot thickening?? *NEWS*

Plot thickening?? *NEWS*Hmmm.....Somebody's interested in this play, and now in for over 3 million dollars.  Breached the 10% threshold!
Lets hope there is some activism here along with the cash.  

Weiss Asset Management LP, Formerly Weiss Capital LLC, Acquires Shares of C.A. Bancorp Inc.
BOSTONApril 23 /CNW/ -- On April 23, 2010 Weiss Asset Management LP, formerly Weiss Capital LLC ("Weiss"), acquired control of 85,000 common shares of C.A. Bancorp Inc. (the "Issuer"), representing approximately 0.32% of the presently issued and outstanding common shares of the Issuer. Those purchases gave Weiss ownership or control of 2,676,200 common shares representing approximately 10.01% of the issued and outstanding common shares of the Issuer reported as of March 31, 2010. The securities were acquired in multiple trades through the facilities of the Toronto Stock Exchange on April 23, 2010 at an average price of approximately CDN$1.38 per common share. The common shares have been acquired for investment purposes and, depending on market and other conditions, Weiss and/or its affiliates may increase or decrease their beneficial ownership, control or direction over common shares (including disposing of all or a portion of the common shares of the Issuer beneficially owned or controlled by them) through market transactions, private agreements, treasury issuances, exercise of options, convertible securities or otherwise.


Bullboard Posts